RSS

rheumatoid arthritis

A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. more

News

Sanofi and Regeneron Pharmaceuticals have announced that the European Commission (EC) has granted marketing authorisation of Kevzara in combination with methotrexate for the treatment of moderately to severely active rheumatoid arthritis in adults more

News

Sanofi and Regeneron Pharmaceuticals have announced the FDA’s approval of Kevzara (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) more

News

Sanofi and Regeneron have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the marketing authorisation of Kevzara (sarilumab). more

News

Eli Lilly and Company, along with its partner Incyte, have seen a drop in the share prices after the FDA rejects its drug to treat rheumatoid arthritis (RA) — baricitinib. more

News

According to the latest report from GlobalData, pipeline agents in the rheumatoid arthritis space are unlikely to address unmet needs by 2025. more

News

Growth will be driven by the uptake of oral Jak inhibitors and non-TNF-alpha biologics more

Xeljanz (tofacitinib citrate) 5 mg and 10 mg twice daily, as monotherapy, inhibited the progression of structural damage and reduced the symptoms of rheumatoid arthritis more

News

A potential new drug that reduces the number of brain cells destroyed by a stroke and also repairs the damage has been discovered by researchers at The University of Manchester. more

News